Trademark Overview
On Tuesday, June 20, 2000, a trademark application was filed for PAREXEL CLINICALLY THINKING with the United States Patent and Trademark Office. The USPTO has given the PAREXEL CLINICALLY THINKING trademark a serial number of 76074199. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Saturday, March 8, 2008. This trademark is owned by Parexel International Corporation. The PAREXEL CLINICALLY THINKING trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:
Market research in the field of international health, the pharmaceutical industry, the biotechnology industry and the medical device and diagnostics industries; business marketing consulting services in the field of international health, the pharmaceutical industry, the biotechnology industry and the medical device and diagnostics industries; market analysis; providing business information, namely, information useful for the introduction of new products in the field of international health, the pharmaceutical industry, the biotechnology industry and the medical device and diagnostics industries; providing statistical information in the field of international health, the pharmaceutical industry, the biotechnology industry and the medical device and diagnostics industries; and data processing services in the field of international health, the pharmaceutical industry, the biotechnology industry and the medical device and diagnostics industries
Consulting services in the field of conducting clinical trials, regulatory affairs, drug development, manufacturing compliance and validation, advanced technology, clinical benchmarking and performance improvement used in connection with the training of professionals in the field of international health, the pharmaceutical industry, the biotechnology industry and the medical device and diagnostics industries; and consultation in the field of publishing relating to conducting clinical trials, regulatory affairs, drug development, manufacturing compliance and validation, advanced technology, clinical benchmarking and performance improvement in the field of international health, the pharmaceutical industry, the biotechnology industry and the medical device and diagnostics industries
